Skip to main content

Table 1 Baseline characteristics of patients in training and validation cohorts

From: A nomogram for predicting 28-day mortality in elderly patients with acute kidney injury receiving continuous renal replacement therapy: a secondary analysis based on a retrospective cohort study

Variables

Total (nā€‰=ā€‰606)

Training Cohorts (nā€‰=ā€‰424)

Validation Cohorts (nā€‰=ā€‰182)

P

Age(years)

74.1ā€‰Ā±ā€‰5.9

73.9ā€‰Ā±ā€‰5.8

74.6ā€‰Ā±ā€‰6.0

0.223

Male (%)

360 (59.4)

246 (58)

114 (62.6)

0.289

Myocardial infarction (%)

85 (14.0)

60 (14.2)

25 (13.7)

0.893

Heart failure (%)

124 (20.5)

91 (21.5)

33 (18.1)

0.352

Cerebrovascular disease (%)

80 (13.2)

50 (11.8)

30 (16.5)

0.118

Peripheral vascular disease (%)

35 (5.8)

24 (5.7)

11 (6)

0.853

dementia, n (%)

39 (6.4)

29 (6.8)

10 (5.5)

0.536

Diabetes mellitus (%)

259 (42.7)

179 (42.2)

80 (44)

0.692

Hypertension (%)

407 (67.2)

289 (68.2)

118 (64.8)

0.424

COPD (%)

56 (9.2)

35 (8.3)

21 (11.5)

0.201

Potassium (mEq/L)

4.7ā€‰Ā±ā€‰1.0

4.7ā€‰Ā±ā€‰1.0

4.6ā€‰Ā±ā€‰1.1

0.308

Bicarbonate (mEq/L)

16.9ā€‰Ā±ā€‰5.2

16.7ā€‰Ā±ā€‰5.3

17.6ā€‰Ā±ā€‰5.0

0.042

Phosphate (mg/dL)

5.5ā€‰Ā±ā€‰2.1

5.6ā€‰Ā±ā€‰2.1

5.3ā€‰Ā±ā€‰2.0

0.073

BMI (kg/m2)

23.5ā€‰Ā±ā€‰4.4

23.5ā€‰Ā±ā€‰4.5

23.4ā€‰Ā±ā€‰4.1

0.917

SBP (mmHg)

112.7ā€‰Ā±ā€‰21.6

113.1ā€‰Ā±ā€‰22.0

111.7ā€‰Ā±ā€‰20.6

0.477

DBP (mmHg)

57.8ā€‰Ā±ā€‰13.6

57.6ā€‰Ā±ā€‰13.3

58.2ā€‰Ā±ā€‰14.4

0.622

MAP (mmHg)

76.2ā€‰Ā±ā€‰14.0

76.4ā€‰Ā±ā€‰14.0

75.7ā€‰Ā±ā€‰13.9

0.598

MV (%)

460 (75.9)

320 (75.5)

140 (76.9)

0.702

Hemoglobin (g/dL)

9.6ā€‰Ā±ā€‰2.1

9.6ā€‰Ā±ā€‰2.2

9.6ā€‰Ā±ā€‰2.0

0.987

Albumin (g/dL)

2.6ā€‰Ā±ā€‰0.6

2.6ā€‰Ā±ā€‰0.6

2.6ā€‰Ā±ā€‰0.6

0.905

APACHE II score

28.3ā€‰Ā±ā€‰7.9

28.3ā€‰Ā±ā€‰8.0

28.1ā€‰Ā±ā€‰7.8

0.794

SOFA score

11.8ā€‰Ā±ā€‰3.5

11.6ā€‰Ā±ā€‰3.4

12.0ā€‰Ā±ā€‰3.5

0.186

AKI cause, (%)

Ā Ā Ā 

0.501

ā€ƒSepsis

418 (69.0)

291 (68.6)

127 (69.8)

Ā 

ā€ƒNephrotoxin

22 (3.6)

19 (4.5)

3 (1.6)

Ā 

ā€ƒIschemia

57 (9.4)

39 (9.2)

18 (9.9)

Ā 

ā€ƒSurgery

53 (8.7)

35 (8.3)

18 (9.9)

Ā 

ā€ƒOthers

56 (9.2)

40 (9.4)

16 (8.8)

Ā 

White blood cell (ĀµL)

12250.0 (7362.5, 19045.0)

12445.0 (7847.5, 19160.0)

11690.0 (6957.5, 18812.5)

0.735

BUN (mg/dL)

52.0 (35.0, 74.0)

53.0 (35.0, 75.2)

48.5 (33.2, 71.0)

0.245

Creatinine (mg/dL)

2.4 (1.7, 3.5)

2.4 (1.7, 3.5)

2.3 (1.7, 3.4)

0.912

CRP (mg/L)

100.1 (39.3, 147.9)

100.0 (37.7, 149.4)

101.4 (45.6, 147.6)

0.605

GFR (ml/min)

24.3 (15.4, 35.9)

24.8 (15.0, 35.6)

23.6 (16.8, 36.3)

0.856

CCI

3.0 (2.0, 4.0)

3.0 (2.0, 4.0)

3.0 (2.0, 4.8)

0.716

  1. Data are expressed as meanā€‰Ā±ā€‰standard deviations, median (interquartile range), or number (%)
  2. Chronic obstructive pulmonary disease, COPD; Charlson comorbidity index, CCI; Body mass index, BMI; Acute kidney injury criteria, AKIN; estimated glomerular filtration rate, GFR; Sequential Organ Failure Assessment score, SOFA score; Acute Physiology and Chronic Health Evaluation II score, APACHE II score; Systolic blood pressure, SBP; Diastolic blood pressure, DBP; Mean arterial pressure, MAP; blood urea nitrogen, BUN; C-reactive protein, CRP